Uncommon Cures
Require An Uncommon Approach
Uncommon Cures Require An Uncommon Approach
Clinical Trial Innovation
Years of
Combined Research
Experience
Introducing Uncommon Cures
Revolutionizing Rare Disease Clinical Research
Welcome to Uncommon Cures, LLC, a trailblazing boutique rare disease clinical trial program dedicated to revolutionizing the way clinical trials for rare diseases are conducted. Our mission is to accelerate the development and delivery of life-changing treatments for patients with rare diseases by streamlining the clinical trial process, reducing costs, prioritizing patient well-being and maximizing the probability of regulatory success.
- Innovation
- Patient-Centricity
- Collaboration
- Integrity
- Diversity
- Inclusion
Uncommon Cures Require Uncommon Thinking
Our Dual Approach
Our unique dual approach combines the centralization of high-risk clinical operations and the decentralization of low-risk clinical operations. This strategy streamlines processes, reduces costs, and maintains the highest quality of patient care throughout the clinical trial lifecycle.
Centralize High-risk Clinical Operations at a Single Location while leveraging multiple locations
- Extensive rare disease clinical and clinical trial expertise
- Pre- and post-approval services
- On-site, full-service hotel and transportation solution to facilitate participation
- One contract, one IRB, one PI, one team!
- Facility near major medical specialty centers, the NIH, the FDA and three major airports.
De-centralize Low-Risk Clinical Operations to Home-Based Solutions
- Extensive rare disease clinical and clinical trial expertise
- Pre- and post-approval services
- On-site, full-service hotel and transportation solution to facilitate participation
- One contract, one IRB, one PI, one team!
- The primary facility is near major medical specialty centers, the NIH, the FDA and three major airports.
- Partner to optimize efficiencies and cost-savings for study and post-marketing periods
- Telehealth platform
- Remote monitoring via wearables
- On-schedule and on-demand laboratory and other diagnostic home delivery
- Immediate secure connection to cloud-based EMR
- Partner to optimize efficiencies and cost-savings for study and post-marketing periods
- Telehealth platform
- Remote monitoring via wearables
- On-schedule and on-demand laboratory and other diagnostic home delivery
- Immediate secure connection to cloud-based EMR
Pioneering Rare Disease Clinical Research Solutions
What We Do
Rare Disease Study Design
Tailoring innovative, patient-centric strategies for efficient, impactful Rare Disease clinical trials.
Clinical Trial - Data Collection Study
Harnessing advanced technology to optimize accurate, secure, and efficient data gathering in clinical trials.
Subject Screening For Clinical Trial
Rigorous, ethical, and efficient screening processes to identify the ideal candidates for successful outcomes.
In House Clinical Trial (No External Facilities)
Comprehensive, fully-integrated clinical trials within our state-of-the-art facilities for seamless, efficient, and high-quality research outcomes.
Clinical Trial With Facilities (External Complex)
Collaborating with specialized, cutting-edge external facilities to expand capabilities and enhance the quality and scope of clinical research outcomes.
Post Marketing Study
Monitoring and evaluating the safety, efficacy, and real-world performance of approved therapies to ensure ongoing patient benefits.
Research Experts
Meet Our Leaders
Marshall Summar, MD
Chief Executive Officer
Dr. Summar is well-known for his pioneering work in caring for children diagnosed with rare diseases. He is now the Chief Executive Officer of Uncommon Cures, LLC, a rare disease clinical trials company focused on physically consolidating trials and using innovative technology to reduce time and cost.
